Eleusis Accelerates Psychedelic Drug Discovery and Development Team with Appointment of David Nichols, Ph.D., as Director of Molecular Pharmacology Post published:January 11, 2021 Post category:Press Release
Cybin Partners with Kernel to Leverage its Breakthrough Neuroimaging Technology for Psychedelic Therapeutics Post published:January 11, 2021 Post category:Press Release
Champignon Brands Announces New CFO and New General Counsel Post published:January 11, 2021 Post category:Press Release
Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer Post published:January 11, 2021 Post category:Press Release
NeonMind Announces Grants Pursuant to Stock Option Plan Post published:January 11, 2021 Post category:Press Release
Lobe Sciences Announces Changes to Board of Directors Post published:January 8, 2021 Post category:Press Release
Review of Bipolar Disorders Confirms Early Diagnosis and Treatment Can Improve Patient Quality of Life Post published:January 8, 2021 Post category:Press Release
COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care Post published:January 8, 2021 Post category:Press Release
Mount Sinai Health System Launches Center for Psychedelic Research Post published:January 7, 2021 Post category:Press Release
BetterLife Announces Formation of Next Generation Psychedelic Research Advisory Board Post published:January 7, 2021 Post category:Press Release